Javascript must be enabled to continue!
Cerebrospinal Fluid Penetration of Ceftolozane-Tazobactam in Critically Ill Patients with an Indwelling External Ventricular Drain
View through CrossRef
The aim of this study was to describe the pharmacokinetics of ceftolozane-tazobactam in plasma and cerebrospinal fluid (CSF) of infected critically ill patients. In a prospective observational study, critically ill patients (≥18 years) with an indwelling external ventricular drain received a single intravenous dose of 3.0 g ceftolozane-tazobactam. Serial plasma and CSF samples were collected for measurement of unbound ceftolozane and tazobactam concentration by liquid chromatography.
Title: Cerebrospinal Fluid Penetration of Ceftolozane-Tazobactam in Critically Ill Patients with an Indwelling External Ventricular Drain
Description:
The aim of this study was to describe the pharmacokinetics of ceftolozane-tazobactam in plasma and cerebrospinal fluid (CSF) of infected critically ill patients.
In a prospective observational study, critically ill patients (≥18 years) with an indwelling external ventricular drain received a single intravenous dose of 3.
0 g ceftolozane-tazobactam.
Serial plasma and CSF samples were collected for measurement of unbound ceftolozane and tazobactam concentration by liquid chromatography.
Related Results
Challenging Management of Postoperative Empyema: A Case Report with Literature Review
Challenging Management of Postoperative Empyema: A Case Report with Literature Review
Abstract
Introduction: Pleural empyema is the collection of pus within the pleural cavity, typically arising as a complication of pneumonia, chest trauma, thoracic surgery, or bact...
In Vitro
Activity of Ceftolozane-Tazobactam against Multidrug-Resistant Nonfermenting Gram-Negative Bacilli Isolated from Patients with Cystic Fibrosis
In Vitro
Activity of Ceftolozane-Tazobactam against Multidrug-Resistant Nonfermenting Gram-Negative Bacilli Isolated from Patients with Cystic Fibrosis
ABSTRACT
Ceftolozane-tazobactam was tested against 58 multidrug-resistant nonfermenting Gram-negative bacilli (35
Pseudomonas aeruginosa
...
Perbedaan cost-effectiveness pengangkatan drain kurang dari 3 hari dengan lebih dari 3 hari pada modified radical mastectomy
Perbedaan cost-effectiveness pengangkatan drain kurang dari 3 hari dengan lebih dari 3 hari pada modified radical mastectomy
Introduction: Modified radical mastectomy (MRM) is a therapeutic choice for operable breast cancer. The most frequent post-surgery complication is seroma formation, and this can be...
Determinación de la actividad de ceftolozane/tazobactam en cepas de Pseudomonas aeruginosa
Determinación de la actividad de ceftolozane/tazobactam en cepas de Pseudomonas aeruginosa
Introducción: El aumento constante de infecciones producidas por Pseudomonas aeruginosa se considera una de las principales causas asociadas a la reducción de alternativas terapéut...
Tazobactam selects for multidrug resistance
Tazobactam selects for multidrug resistance
Abstract
Piperacillin-Tazobactam is a β-lactam/β-lactamase inhibitor combination that is amongst the most prescribed antimicrobials in hospital medicine. Piperacillin is ...
Tazobactam selects for multidrug resistance
Tazobactam selects for multidrug resistance
Abstract
Piperacillin-Tazobactam is a β-lactam/β-lactamase inhibitor combination which is amongst the most prescribed antimicrobials in hospital ...
Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction
Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction
Evaluation of dosing regimens for critically ill patients requires pharmacokinetic data in this population. This prospective observational study aimed to describe the population ph...
A comparative study of laparoscopic cholecystectomy with and without abdominal drain
A comparative study of laparoscopic cholecystectomy with and without abdominal drain
Background: Laparoscopic cholecystectomy (LC) has been considered the Gold-standard for the management of benign gallbladder disease. With increasing surgeon experience and advance...

